Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -140,956 | 515,837 | 617,440 | 442,128 | 518,621 |
| Depreciation Amortization | -3,727 | -2,160 | 3,515 | 4,880 | 2,625 |
| Income taxes - deferred | N/A | -15,186 | N/A | N/A | N/A |
| Accounts receivable | 2,093 | 770,038 | 491,872 | 433,689 | -450,082 |
| Accounts payable and accrued liabilities | 6,564 | 797 | -2,003 | 2,444 | 3,829 |
| Other Working Capital | 10,725 | 665,367 | 535,549 | 590,548 | 3,914 |
| Other Operating Activity | -481 | -271,440 | -18,246 | 36,536 | 471,182 |
| Operating Cash Flow | $-125,782 | $1,663,253 | $1,628,127 | $1,510,225 | $550,089 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 104,946 | -1,125,455 | -984,916 | -341,293 | -89,563 |
| PPE Investments | -6,867 | -68,006 | -55,410 | -36,428 | -15,829 |
| Investing Cash Flow | $98,079 | $-1,193,461 | $-1,040,326 | $-377,721 | $-105,392 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | -183 | -124 | N/A |
| Debt Repayment | -66 | -260 | N/A | N/A | -64 |
| Common Stock Issued | 2,410 | 36,218 | 34,130 | 32,086 | 28,946 |
| Other Financing Activity | 0 | -1,197 | -1,197 | -1,197 | -1,197 |
| Financing Cash Flow | $2,344 | $34,761 | $32,750 | $30,765 | $27,685 |
| Beginning Cash Position | 867,968 | 363,415 | 363,415 | 363,415 | 363,415 |
| End Cash Position | 842,609 | 867,968 | 983,966 | 1,526,684 | 835,797 |
| Net Cash Flow | $-25,359 | $504,553 | $620,551 | $1,163,269 | $472,382 |
| Free Cash Flow | |||||
| Operating Cash Flow | -125,782 | 1,663,253 | 1,628,127 | 1,510,225 | 550,089 |
| Capital Expenditure | -6,867 | -68,006 | -55,432 | -36,439 | -15,841 |
| Free Cash Flow | -132,649 | 1,595,247 | 1,572,695 | 1,473,786 | 534,248 |